FR2464956B1 - - Google Patents

Info

Publication number
FR2464956B1
FR2464956B1 FR8020069A FR8020069A FR2464956B1 FR 2464956 B1 FR2464956 B1 FR 2464956B1 FR 8020069 A FR8020069 A FR 8020069A FR 8020069 A FR8020069 A FR 8020069A FR 2464956 B1 FR2464956 B1 FR 2464956B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8020069A
Other versions
FR2464956A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SRI International Inc
Original Assignee
SRI International Inc
Stanford Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SRI International Inc, Stanford Research Institute filed Critical SRI International Inc
Publication of FR2464956A1 publication Critical patent/FR2464956A1/fr
Application granted granted Critical
Publication of FR2464956B1 publication Critical patent/FR2464956B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8020069A 1979-09-17 1980-09-17 Procede de production de 10-deazaminopterine et de ses derives 10-alkyliques, composes obtenus et composition pharmaceutique les contenant Granted FR2464956A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/075,913 US4393064A (en) 1976-03-05 1979-09-17 Process and composition for treatment of leukemia and process for preparing the same
US06/233,280 US4369319A (en) 1979-09-17 1981-02-10 10-Alkyl-10-deazaminopterins
US06/344,564 US4433147A (en) 1979-09-17 1982-01-22 Process for preparing 10-deazaminopterins

Publications (2)

Publication Number Publication Date
FR2464956A1 FR2464956A1 (fr) 1981-03-20
FR2464956B1 true FR2464956B1 (fr) 1983-04-29

Family

ID=27372768

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8020069A Granted FR2464956A1 (fr) 1979-09-17 1980-09-17 Procede de production de 10-deazaminopterine et de ses derives 10-alkyliques, composes obtenus et composition pharmaceutique les contenant
FR8107140A Granted FR2477152A1 (fr) 1979-09-17 1981-04-09 Derives 10-alkyliques de 10-deazaminopterine et leurs sels et composition pharmaceutique les contenant

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8107140A Granted FR2477152A1 (fr) 1979-09-17 1981-04-09 Derives 10-alkyliques de 10-deazaminopterine et leurs sels et composition pharmaceutique les contenant

Country Status (9)

Country Link
US (3) US4393064A (fr)
JP (2) JPS5651482A (fr)
AU (1) AU540326B2 (fr)
BE (1) BE885255A (fr)
CA (1) CA1139752A (fr)
DE (1) DE3034843A1 (fr)
FR (2) FR2464956A1 (fr)
GB (1) GB2058770B (fr)
ZA (1) ZA805474B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140104A (en) * 1982-03-09 1992-08-18 Cytogen Corporation Amine derivatives of folic acid analogs
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
JPS6237911A (ja) * 1985-08-12 1987-02-18 Sumitomo Special Metals Co Ltd 異方性フエライト磁石
US4746659A (en) * 1985-12-30 1988-05-24 Sri International Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
JPS62281878A (ja) * 1986-02-26 1987-12-07 Taisho Pharmaceut Co Ltd アザアントラセン化合物
US4833145A (en) * 1986-06-30 1989-05-23 The Trustees Of Princeton University 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US4940713A (en) * 1988-04-15 1990-07-10 Burroughs Wellcome Co. Substituted glutamic acids
US5019577A (en) * 1988-04-15 1991-05-28 Burroughs Welcome Co. Novel compounds and use
FR2640638B1 (fr) * 1988-12-20 1991-02-15 Commissariat Energie Atomique Bioreacteur et dispositif pour la culture de cellules animales
JPH03118740A (ja) * 1989-09-29 1991-05-21 Hitachi Metals Ltd アークセグメント磁石
US4996206A (en) * 1989-12-11 1991-02-26 The Trustees Of Princeton University N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
US5073554A (en) * 1990-01-18 1991-12-17 Nair Madhavan G Two non-polyglutamatable antifolates
US5030634A (en) * 1990-03-29 1991-07-09 Krumdieck Carlos L 10-deazaaminopterin: a new arthritis remittive drug
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US5159079A (en) * 1991-12-20 1992-10-27 Eli Lilly And Company 2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids
US5354751A (en) * 1992-03-03 1994-10-11 Sri International Heteroaroyl 10-deazaamino-pterine compounds and use for rheumatoid arthritis
US5374726A (en) * 1992-03-03 1994-12-20 Degraw; Joseph I. Process for preparing 10-deazaaminopterins and 5,10-and 8,10-dideazaaminopterins from pteroic dicarboxylic acid diesters
WO1993022315A1 (fr) * 1992-04-29 1993-11-11 Sri International Heteroaroyl-10-desazaaminopterines pour le traitement des inflammations
US5260296A (en) * 1992-05-13 1993-11-09 Nair Madhavan G Thiophene substituted antitumor antifolates
US5534514A (en) * 1992-10-27 1996-07-09 San Diego State University Anti-neoplastic compositions and methods for application thereof
US5550128A (en) * 1994-09-09 1996-08-27 Nair; Madhavan G. Enantiomers of gamma methylene 10-deaza aminopterin and process for preparing the same
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
PT944389E (pt) * 1996-07-17 2008-12-03 Sloan Kettering Inst Cancer Composições purificadas de 10-propargil-10-desaza-aminopterina e métodos para a sua utilização no tratamento de tumores
AU7624498A (en) * 1996-12-02 1998-06-29 Bionumerik Pharmaceuticals, Inc. Process for making gamma-methylene-10-deazaaminopterin (MDAM)
ES2229803T3 (es) * 1998-12-28 2005-04-16 4 Aza Bioscience Nv Efectos inmunosupresivos de derivados de pteridina.
RU2346686C2 (ru) 2002-01-14 2009-02-20 Новартис Аг Комбинации, включающие эпотилоны и антиметаболиты
US20040092739A1 (en) * 2002-11-13 2004-05-13 Zejun Xiao Process for synthesizing antifolates
US20080188479A1 (en) * 2004-05-30 2008-08-07 Sloan-Kettering Institute For Cancer Research Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin
US8263354B2 (en) * 2004-05-30 2012-09-11 Sloan-Kettering Institute For Cancer Research Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin
ES2313365T3 (es) * 2004-05-30 2009-03-01 Sloan-Kettering Institute For Cancer Research Tratamiento del linfoma de celulas t utilizando 10-propargil-10-deazaaminopterina.
US9901578B2 (en) 2007-08-17 2018-02-27 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20090048262A1 (en) * 2007-08-17 2009-02-19 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20100248249A1 (en) * 2007-08-17 2010-09-30 Allos Therapeutics, Inc. Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
CA2788554C (fr) 2010-02-02 2017-07-25 Allos Therapeutics, Inc. Diastereo-isomeres optiquement purs de 10-propargyl-10-deazaaminopterine, et leurs procedes d'utilisation
CN103265544B (zh) * 2013-05-27 2015-05-20 苏州明锐医药科技有限公司 普拉曲沙的制备方法
CN103274943B (zh) * 2013-05-24 2015-01-21 苏州明锐医药科技有限公司 4-[1-(2-丙炔基)-3,4-二氧代正丁基]苯甲酸酯及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA771315B (en) * 1976-03-05 1978-05-30 Stanford Research Inst Process and composition for treatment of leukemia and other tumors
US4172200A (en) * 1978-06-15 1979-10-23 Southern Research Institute Process for the preparation of 10-deazaaminopterin and related compounds

Also Published As

Publication number Publication date
BE885255A (fr) 1981-01-16
US4369319A (en) 1983-01-18
AU540326B2 (en) 1984-11-15
US4433147A (en) 1984-02-21
CA1139752A (fr) 1983-01-18
GB2058770A (en) 1981-04-15
US4393064A (en) 1983-07-12
FR2464956A1 (fr) 1981-03-20
ZA805474B (en) 1981-08-26
DE3034843A1 (de) 1981-06-11
GB2058770B (en) 1983-05-25
JPH0340029B2 (fr) 1991-06-17
JPH0334979A (ja) 1991-02-14
JPH034553B2 (fr) 1991-01-23
FR2477152A1 (fr) 1981-09-04
FR2477152B1 (fr) 1983-03-11
JPS5651482A (en) 1981-05-09
DE3034843C2 (fr) 1989-10-05
AU6243980A (en) 1981-03-26

Similar Documents

Publication Publication Date Title
FR2477152B1 (fr)
BR8002583A (fr)
BR8006808A (fr)
FR2448045B1 (fr)
DE2902259C2 (fr)
FR2448463B1 (fr)
DE3021029C2 (fr)
FR2445819B1 (fr)
FR2448290B1 (fr)
FR2447776B1 (fr)
DE2945006C2 (fr)
FR2445705B3 (fr)
FR2447665B1 (fr)
FR2445828B1 (fr)
FR2447552B1 (fr)
FR2447143B1 (fr)
AT364253B (fr)
AU78391S (fr)
AU79200S (fr)
AU78386S (fr)
AU78390S (fr)
AU78270S (fr)
AU79826S (fr)
AU79559S (fr)
AU77763S (fr)

Legal Events

Date Code Title Description
ST Notification of lapse